Identification and treatment of cystic fibrosis-related diabetes - A survey of current medical practice in the US

被引:27
作者
Allen, HF
Klingensmith, GJ
Gay, EC
Hamman, RF
机构
[1] Baystate Med Ctr, Childrens Hosp, Dept Pediat, Springfield, MA 01199 USA
[2] Tufts Univ, Sch Med, Dept Pediat, Boston, MA 02111 USA
[3] Univ Colorado, Sch Med, Dept Prevent Med & Biometr, Denver, CO USA
[4] Univ Colorado, Sch Med, Dept Pediat, Denver, CO USA
关键词
D O I
10.2337/diacare.21.6.943
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
OBJECTIVE - To describe physicians' attitudes and practices in screening for and treating abnormalities in glucose homeostasis in cystic fibrosis (CF) patients and to test the hypotheses that guidelines for screening for CF-related diabetes (CFRD) are not followed at most centers and that screening and treatment vary by the care provider's background. RESEARCH DESIGN AND METHODS - This cross-sectional survey included three groups of physicians: 1) 593 members of the Lawson Wilkins Pediatric Endocrine Society (LWPES), 2) 462 members of the pediatric assembly of the American Thoracic Society (ATS), and 3) 194 directors of cystic fibrosis centers (CFD). A mailed questionnaire was used for the survey. RESULTS-The overall response rate was 67%. Of these, 224 LWPES 143 ATS and 135 CFD physicians reported actively seeing CF patients. About two-thirds of CF ph physicians (ATS and CFD) reported routine screening for impaired glucose tolerance (IGT) in asymptomatic CF patients; a random glucose is most often used (60%), followed by HbA(1c) (50%), urine glucose (44%), fasting glucose (21%), and oral glucose tolerance test (2%). Only 40% of LWPES physicians reported intervening for stress-induced hyperglycemia, but 61% reported use of insulin for persistent IGT. Management of CFRD was similar for all groups; most physicians used insulin (91%). LWPES recommended more intensive glucose testing and nutritional guidelines than did ATS/CFD (P < 0.0001), LWPES reported less concern about risks of diabetes complications (P < 0.0001) and the importance of minimizing burdensome interventions (P < 0.01). All groups considered weight management a top priority. CONCLUSIONS - Screening for IGT is not routinely done in CF patients and screening tests var): Greater agreement exists on methods of treating patients with persistent IGT or CFRD, although goals and aggressiveness of treatment vary with the provider's background. A consensus conference is recommended.
引用
收藏
页码:943 / 948
页数:6
相关论文
共 13 条
  • [1] ALLEN JL, 1986, NEW ENGL J MED, V315, P764
  • [2] [Anonymous], 1985, World Health Organ Tech Rep Ser, V727, P1
  • [3] *CYST FIBR FDN, 1990, CONS C CF REL DIAB M, V1, P1
  • [4] DOLAN TF, 1986, NEW ENGL J MED, V314, P991
  • [5] DIABETES-MELLITUS ASSOCIATED WITH CYSTIC-FIBROSIS
    FINKELSTEIN, SM
    WIELINSKI, CL
    ELLIOTT, GR
    WARWICK, WJ
    BARBOSA, J
    WU, SC
    KLEIN, DJ
    [J]. JOURNAL OF PEDIATRICS, 1988, 112 (03) : 373 - 377
  • [6] THE CHANGING EPIDEMIOLOGY OF CYSTIC-FIBROSIS
    FITZSIMMONS, SC
    [J]. JOURNAL OF PEDIATRICS, 1993, 122 (01) : 1 - 9
  • [7] GLUCOSE INTOLERANCE IN CYSTIC FIBROSIS
    HANDWERG.S
    ROTH, J
    GORDEN, P
    DISANTAG.P
    CARPENTE.DF
    PETER, G
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1969, 281 (09) : 451 - &
  • [8] DIABETES-MELLITUS IN DANISH CYSTIC-FIBROSIS PATIENTS - PREVALENCE AND LATE DIABETIC COMPLICATIONS
    LANNG, S
    THORSTEINSSON, B
    LUNDANDERSEN, C
    NERUP, J
    SCHIOTZ, PO
    KOCH, C
    [J]. ACTA PAEDIATRICA, 1994, 83 (01) : 72 - 77
  • [9] INFLUENCE OF THE DEVELOPMENT OF DIABETES-MELLITUS ON CLINICAL STATUS IN PATIENTS WITH CYSTIC-FIBROSIS
    LANNG, S
    THORSTEINSSON, B
    NERUP, J
    KOCH, C
    [J]. EUROPEAN JOURNAL OF PEDIATRICS, 1992, 151 (09) : 684 - 687
  • [10] BLOOD GLUCOSE AND SERUM INSULIN LEVELS IN CHILDREN WITH CYSTIC FIBROSIS
    MILNER, AD
    [J]. ARCHIVES OF DISEASE IN CHILDHOOD, 1969, 44 (235) : 351 - &